Cherian T, Skinnider L F, Wright J L, Komjathy G
Can Med Assoc J. 1978 Sep 9;119(5):435-41.
In a retrospective clinical study of 208 previously untreated persons with non-Hodgkin's lymphomas the disorders were classified and staged according to the histopathologic criteria of Rappaport, Winter and Hicks and the Ann Arbor clinical staging classification.Nodular types constituted 22% and diffuse types 78% of the lymphomas. The nodular lymphomas were slightly more common in females and were clustered in the age range 30 to 90 years. The diffuse lymphomas were slightly more common in males; the age distribution was bimodal, with one peak in the age range 10 to 19 years and the other in the age range 60 to 69 years, but when the age distribution of the general population in which the lymphomas occurred was taken into account, the incidence of these lymphomas was found to be significantly higher (P < 0.001) in persons more than 69 years of age than in those 40 to 69 years of age.SURVIVAL CORRELATED WITH HISTOPATHOLOGIC TYPE: persons with nodular (follicular) lymphomas and diffuse lymphocytic well differentiated lymphomas had a significantly greater survival (P < 0.05) than those with other diffuse lymphomas. No significant difference in survival was noticed between persons with nodal and extranodal lymphomas.While Rappaport and colleagues' criteria are still very useful, it is important to recognize the nodular lymphoma as a specific entity requiring generally different management from diffuse lymphomas. Appreciation of the different biologic behaviour of the various lymphomas is important to clinicians planning therapy.
在一项对208例未经治疗的非霍奇金淋巴瘤患者的回顾性临床研究中,根据拉帕波特、温特和希克斯的组织病理学标准以及安阿伯临床分期分类对疾病进行分类和分期。结节型淋巴瘤占淋巴瘤的22%,弥漫型占78%。结节型淋巴瘤在女性中略为常见,集中在30至90岁年龄范围。弥漫型淋巴瘤在男性中略为常见;年龄分布呈双峰型,一个高峰在10至19岁年龄范围,另一个在60至69岁年龄范围,但当考虑淋巴瘤所发生的总体人群的年龄分布时,发现69岁以上人群中这些淋巴瘤的发病率显著高于40至69岁人群(P<0.001)。生存与组织病理学类型相关:结节型(滤泡型)淋巴瘤和弥漫性淋巴细胞高度分化型淋巴瘤患者的生存期明显长于其他弥漫型淋巴瘤患者(P<0.05)。结节性淋巴瘤和结外淋巴瘤患者的生存期无显著差异。虽然拉帕波特及其同事的标准仍然非常有用,但重要的是要认识到结节型淋巴瘤是一种特定的实体,通常需要与弥漫型淋巴瘤采用不同的治疗方法。了解各种淋巴瘤不同的生物学行为对规划治疗的临床医生很重要。